Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 12 (December)

1. Cannabinoid receptors as novel targets for the treatment of melanoma.
   FASEB J, 20(14): 2633-5. [Abstract] [Full-text]
2. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
   Mol Immunol, 44(8): 2036-46. [Abstract] [Full-text]
3. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
   Oncogene, 25(58): 7618-34. [Abstract] [Full-text]
4. The Src signaling pathway: a potential target in melanoma and other malignancies.
   Expert Opin Ther Targets, 11(1): 91-100. [Abstract] [Full-text]
5. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
   Am J Surg, 192(6): 878-81. [Abstract] [Full-text]
6. Quantitative discrimination of pigmented lesions using three-dimensional high-resolution ultrasound reflex transmission imaging.
   J Invest Dermatol, 127(1): 189-95. [Abstract] [Full-text]
7. Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands.
   J Invest Dermatol, 127(1): 183-8. [Abstract] [Full-text]
8. Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.
   Oncogene, 25(59): 7714-22. [Abstract] [Full-text]
9. Dickkopf-1 activates cell death in MDA-MB435 melanoma cells.
   Biochem Biophys Res Commun, 352(3): 675-80. [Abstract] [Full-text]
10. Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases.
    Int J Surg Pathol, 15(1): 20-5. [Abstract] [Full-text]
11. Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
    J Clin Oncol, 24(36): 5716-24. [Abstract] [Full-text]
12. Dimethylfumarate impairs melanoma growth and metastasis.
    Cancer Res, 66(24): 11888-96. [Abstract] [Full-text]
13. Cytotoxic activity of Apomine is due to a novel membrane-mediated cytolytic mechanism independent of apoptosis in the A375 human melanoma cell line.
    Invest New Drugs, 25(2): 107-14. [Abstract] [Full-text]
14. A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.
    Invest New Drugs, 25(2): 155-9. [Abstract] [Full-text]
15. Hypersensitivity reaction against patent blue during sentinel lymph node removal in three melanoma patients.
    Am J Surg, 193(1): 122-4. [Abstract] [Full-text]
16. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
    Expert Rev Anticancer Ther, 7(1): 79-88. [Abstract] [Full-text]
17. Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells.
    Cancer Immunol Immunother, 56(3): 391-6. [Abstract] [Full-text]
18. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population.
    Cancer Immunol Immunother, 56(3): 371-9. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.